Howard Hughes Medical Institute

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Howard Hughes Medical Institute reported 2 stock positions worth $630.4 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 99.6% of the portfolio, followed by Bioage Labs (BIOA, 0.4%). Compared with Q2 2024, it opened 1 new position and added to 1. The biggest buy was a new position in Bioage Labs (BIOA).

Most Recent 13F
Q2 2026
Location
Chevy Chase, MD
CIK
0000810386
Portfolio Value
$630.4M (Q3 2024)
SEC Filing
0000950123-24-011467 ↗ filed Nov 14, 2024

Holdings Value

0$200.0M$400.0M$600.0M$800.0M Q1 2024: $332.9M Q1 2024 Q2 2024: $466.2M Q2 2024 Q3 2024: $630.4M $630.4M Q3 2024 Q4 2024: $568.4M Q4 2024 Q1 2025: $202.2M Q1 2025 Q2 2025: $250.9M Q2 2025 Q3 2025: $170.6M Q3 2025 Q4 2025: $174.7M Q4 2025 Q1 2026: $415.8M Q1 2026 Q2 2026: $445.4M Q2 2026

Holdings 2 stocks · $630.4M
SPY SS SPDR S&P 500 ETF Trust-US 99.62% 1,094,663 $628.1M Add +27.8%
BIOA Bioage Labs Inc. 0.38% 113,765 $2.4M New

Portfolio Sells Q2 2024 → Q3 2024
None this quarter.

Portfolio Buys Q2 2024 → Q3 2024
BIOA Bioage Labs Inc. New 0.38% +0.38
SPY SS SPDR S&P 500 ETF Trust-US Add +27.8% 99.62% −0.38

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 30$445.4MNVDA, AAPL, GOOGL, MSFT, TSM
Q1 2026 31$415.8MSPY, NVDA, AAPL, GOOGL, MSFT
Q4 2025 500$174.7MSPY, NVDA, AAPL, MSFT, AMZN
Q3 2025 500$170.6MSPY, NVDA, MSFT, AAPL, AMZN
Q2 2025 501$250.9MSPY, NVDA, MSFT, AAPL, AMZN
Q1 2025 2$202.2MSPY, BIOA
Q4 2024 2$568.4MSPY, BIOA
Q3 2024 2$630.4MSPY, BIOA
Q2 2024 1$466.2MSPY
Q1 2024 2$332.9MSPY, PCT